BCD Bioscience Overview
- Founded
- 2019
- Status
- Private
- Latest Deal Type
- Series A1
- Latest Deal Amount
- $4M
- Investors
- 2
BCD Bioscience General Information
Description
Developer of naturally-derived oligosaccharides designed to enhance health. The company's oligosaccharides create a comprehensive oligosaccharide library and design a roadmap that connects precise carbohydrate structures with their functions as prebiotics and immunomodulators thereby developing pharmaceutical and food ingredients, enabling clients to get and commercialize novel prebiotics, synbiotics and immunomodulatory therapies for human and animal health.
Contact Information
Website
Formerly Known As
Calyxo Biosystems
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
- 231 G Street
- Suite 24
- Davis, CA 95616
- United States
BCD Bioscience Timeline
BCD Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A1) | 24-May-2020 | $4M | 000 | 000 | Completed | Generating Revenue |
| 1. Grant | 29-Oct-2019 | 00000 | Completed | Startup |
BCD Bioscience Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Steve Watkins Ph.D | Chief Executive Officer & Board Member | ||
| Bruce German Ph.D | Co-Founder | ||
| David Mills Ph.D | Co-Founder | ||
| Carlito Lebrilla Ph.D | Co-Founder & Board Member |
BCD Bioscience Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Carlito Lebrilla Ph.D | Self | Co-Founder & Board Member | 000 0000 |
| Steve Watkins Ph.D | BCD Bioscience | Chief Executive Officer & Board Member | 000 0000 |
BCD Bioscience Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| iSelect Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Bill & Melinda Gates Foundation | Not-For-Profit Venture Capital | 000 0000 | 000000 0 |